Literature DB >> 7619660

Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.

K J Belton1, S C Lewis, S Payne, M D Rawlins, S M Wood.   

Abstract

1. Attitudes of doctors to the Committee on Safety of Medicines' (CSM) adverse drug reaction (ADR) reporting scheme were investigated in order to assess their understanding of the purposes of the scheme and to identify reasons for failing to report suspected adverse drug reactions. 2. A postal questionnaire and letter of invitation were sent to 500 doctors who were randomly selected from the 1992 Medical Directory. A reminder letter and a second copy of the questionnaire were sent to non-responders after 4 weeks. 3. 284 (57%) responded to the questionnaire. Of these, 179 (63%) stated that they had previously reported an ADR to the CSM or a pharmaceutical manufacturer. 77% of general practitioners stated that they had reported one or more ADRs compared with 55% of hospital doctors. 4. Reasons for under-reporting included lack of time, lack of report forms and the misconception that absolute confidence in the diagnosis of an adverse reaction was important in the decision to send in a report. 5. An investigation of seven commonly proposed reasons for under-reporting showed that on the whole they did not apply. 6. Most doctors knew the types of reactions that the Committee on Safety of Medicines seeks reports for but only 38% knew the precise meaning of the Committee on Safety of Medicines' black triangle symbol. There also seemed to be confusion about some of the purposes of the adverse drug reaction reporting scheme. 7. The number of reporting doctors is much higher than has previously been estimated.(ABSTRACT TRUNCATED AT 250 WORDS)

Mesh:

Year:  1995        PMID: 7619660      PMCID: PMC1364995          DOI: 10.1111/j.1365-2125.1995.tb04440.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Attitudes to adverse drug reaction reporting in the Northern Region.

Authors:  D N Bateman; G L Sanders; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

2.  Demography of the UK adverse reactions register of spontaneous reports.

Authors:  C J Speirs; J P Griffin; J C Weber; M Glen-Bott
Journal:  Health Trends       Date:  1984-08

3.  Physician knowledge, attitudes, and behavior related to reporting adverse drug events.

Authors:  A S Rogers; E Israel; C R Smith; D Levine; A M McBean; C Valente; G Faich
Journal:  Arch Intern Med       Date:  1988-07

4.  Spontaneous reporting of adverse drug reactions. I: the data.

Authors:  M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

5.  Factors determining physician reporting of adverse drug reactions. Comparison of 2000 spontaneous reports with surveillance studies at the Massachusetts General Hospital.

Authors:  J Koch-Weser; V W Sidel; R H Sweet; P Kanarek; A E Eaton
Journal:  N Engl J Med       Date:  1969-01-02       Impact factor: 91.245

  5 in total
  64 in total

1.  Attitudinal survey of voluntary reporting of adverse drug reactions.

Authors:  I A Eland; K J Belton; A C van Grootheest; A P Meiners; M D Rawlins; B H Stricker
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

2.  Underreporting of adverse drug reactions: attitudes of Irish doctors.

Authors:  D Williams; J Feely
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

3.  A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.

Authors:  D Sweis; I C Wong
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

4.  Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting.

Authors:  C F Green; D R Mottram; P H Rowe; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

5.  Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.

Authors:  A Vallano; G Cereza; C Pedròs; A Agustí; I Danés; C Aguilera; J M Arnau
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

6.  Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; J J Gestal-Otero
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

8.  A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?

Authors:  M Bäckström; T Mjörndal
Journal:  Eur J Clin Pharmacol       Date:  2006-03-30       Impact factor: 2.953

9.  Data mining in pharmacovigilance: lessons from phantom ships.

Authors:  Manfred Hauben; Lester Reich; Eugène P Van Puijenbroek; Charles M Gerrits; Vaishali K Patadia
Journal:  Eur J Clin Pharmacol       Date:  2006-08-03       Impact factor: 2.953

10.  Post-marketing studies: the work of the Drug Safety Research Unit.

Authors:  F J Mackay
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.